Tuberc Respir Dis.  2012 Sep;73(3):137-142. 10.4046/trd.2012.73.3.137.

Year-in-Review of Lung Cancer

Affiliations
  • 1Department of Internal Medicine, Konyang University Hospital, Konyang University College of Medicine, Daejeon, Korea. sk1609@hanmail.net

Abstract

In the last several years, we have made slow but steady progress in understanding molecular biology of lung cancer. This review is focused on advances in understanding the biology of lung cancer that have led to proof of concept studies on new therapeutic approaches. The three selected topics include genetics, epigenetics and non-coding RNA. This new information represents progress in the integration of molecular mechanisms that to identify more effective ways to target lung cancer.

Keyword

Lung Neoplasms; Molecular Biology; Genetics; Epigenomics; RNA, Untranslated
Full Text Links
  • TRD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr